1672-7118
2016 Issue 1
..............page:1-2
Current practices and guidelines for clinical next-generation sequencing oncology testing
Samuel P. Strom;
Samuel P. Strom;
..............page:3-11
Changing paradigm of cancer therapy：precision medicine by next-generation sequencing
Yuan Xue;,William R Wilcox;
Yuan Xue;,William R Wilcox;
..............page:12-18
The potential for liquid biopsies in the precision medical treatment of breast cancer
Victoria A Forte;,Dany K Barrak;,Mostafa Elhodaky;,Lily Tung;,Anson Snow;,Julie E Lang;
Victoria A Forte;,Dany K Barrak;,Mostafa Elhodaky;,Lily Tung;,Anson Snow;,Julie E Lang;
..............page:19-40
..............page:41-54
Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing
Christine Stanislaw;,Yuan Xue;,William R Wilcox;
Christine Stanislaw;,Yuan Xue;,William R Wilcox;
..............page:55-67
Establishment and application of a multiplex genetic mutation-detection method of lung cancer based on MassARRAY platform
Hong-Xia Tian;,Xu-Chao Zhang;,Zhen Wang;,Jian-Guang Chen;,Shi-Liang Chen;,Wei-Bang Guo;,Yi-Long Wu;
Hong-Xia Tian;,Xu-Chao Zhang;,Zhen Wang;,Jian-Guang Chen;,Shi-Liang Chen;,Wei-Bang Guo;,Yi-Long Wu;
..............page:68-76
Alterations in genes other thanEGFR/ALK/ROS1 in non-small cell lung cancer：trials and treatment options
Arpita Desai;,Smitha P Menon;,Grace K Dy;
Arpita Desai;,Smitha P Menon;,Grace K Dy;
..............page:77-86
Changing the paradigm：the potential for targeted therapy in laryngeal squamous cell carcinoma
Megan L Ludwig;,Andrew C Birkeland;,Rebecca Hoesli;,Paul Swiecicki;,Matthew E Spector;,J Chad Brenner;
Megan L Ludwig;,Andrew C Birkeland;,Rebecca Hoesli;,Paul Swiecicki;,Matthew E Spector;,J Chad Brenner;
..............page:87-100
Evolving role of adiponectin in cancer-controversies and update
Arnav Katira;,Peng H Tan;
Arnav Katira;,Peng H Tan;
..............page:101-119
Colorectal cancer carcinogenesis：a review of mechanisms
Kanwal Tariq;,Kulsoom Ghias;
Kanwal Tariq;,Kulsoom Ghias;
..............page:120-135
Second-line panitumumab as a triweekly dose for patients with wild-typeKRAS exon 2 metastatic colorectal cancer：a single-institution experience
Mohamed A. Daoud;,Engy M. Aboelnaga;,Wael M. Mohamed;
Mohamed A. Daoud;,Engy M. Aboelnaga;,Wael M. Mohamed;
..............page:136-141
Is adjuvant chemotherapy necessary for patients with microinvasive breast cancer after surgery?
Hai-Fei Niu;,Li-Juan Wei;,Jin-Pu Yu;,Zhen Lian;,Jing Zhao;,Zi-Zheng Wu;,Jun-Tian Liu;
Hai-Fei Niu;,Li-Juan Wei;,Jin-Pu Yu;,Zhen Lian;,Jing Zhao;,Zi-Zheng Wu;,Jun-Tian Liu;
..............page:142-149
..............page:150-155